Selenium-containing ruthenium complex synergizes with natural killer cells to enhance immunotherapy against prostate cancer via activating TRAIL/FasL signaling
- Resource Type
- Article
- Source
- In
Biomaterials October 2019 219 - Subject
- Language
- ISSN
- 0142-9612